Home

Third Rock Ventures IV reported a 9.3% stake in Maze Therapeutics MAZE · 4,473,958 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
9.3%
Last report
13.9% · filed 25/05/09
Shares held
4,473,958 sh
Class
Common Stock, $0.001 par value per share
Event date
25/12/31
Filed
26/02/13

9.3% stake · −4.6pp from the last report

Stake
9.3%
Last report
13.9%
Since last report
−4.6pp

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/01~01/30

Third Rock Ventures IV's other 5% stake reports

  • Third Rock Ventures IV

    5% stakeTango Therapeutics

    4.74% stake

    Filed 02/10

  • Third Rock Ventures IV

    5% stakeTango Therapeutics

    5.85% stake

    Filed 25/11/21

  • Third Rock Ventures IV

    5% stakeTango Therapeutics

    6.97% stake

    Filed 25/11/14

  • Third Rock Ventures IV

    5% stakeMaze Therapeutics

    13.9% stake

    Filed 25/05/09